Sceletium Tortuosum II 300 mg By HBC Protocols Overview & Drug Interactions
Check For Interactions With Sceletium Tortuosum II 300 mg
Supplement: Sceletium Tortuosum II 300 mg by HBC Protocols
Sceletium Tortuosum II 300 mg Label Images
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Sceletium tortuosum powder
| Ingredient Group | Sceletium |
|---|---|
| Category | botanical |
Drugs that interact with Sceletium Tortuosum II 300 mg by HBC Protocols
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
Label Information
Supplement Facts:
| Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
|---|---|
| Minimum serving Sizes: |
1 Capsule(s)
|
| Maximum serving Sizes: |
1 Capsule(s)
|
| Servings per container | 60 |
| UPC/BARCODE | 678940750264 |
| Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
|---|---|---|---|
| Sceletium tortuosum powder |
300 mg
|
Sceletium |
--
|
| Other Ingredients: |
Rice powder
Magnesium Stearate
Silicon Dioxide
Maltodextrin
|
|---|
Label Statments:
| Formulation |
- Contains no sugar, starch, yeast, artificial colors, preservatives or dairy products.
|
|---|---|
| Precautions |
- Keep out of the reach of children.
- Not to be taken by pregnant women or those using MAO inhibitors.
- People taking psychiatric, anti-anxiety or anti-depressant medication should discuss the concomitant use of Sceletium tortuosum-containing products with their healthcare professional.
|
| FDA Statement of Identity |
- Dietary Supplement
|
| Suggested/Recommended/Usage/Directions |
- Dosage: Minimum one capsule per day.
|
| General Statements |
- Sceletium tortuosum has been demonstrated to be clinically effective in human studies. Sceletium has a self-affirmed GRAS (generally recognized as safe) status.
|
| FDA Disclaimer Statement |
- This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
|
Brand Information
See all products by this brand
| Manufacturer | |
|---|---|
| Name | HBC Protocols, Inc |
| Street Address | P.O. Box 712445 |
| City | Los Angeles |
| State | CA |
| ZipCode | 90071 |
| Phone Number | 888.497.3742 |
| Web Address | www.hbcprotocols.com |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.